Leucine Rich Bio partners with Trinature Wellness to launch BugSpeaks in Malaysia

Leucine Rich Bio, a microbiome company in South Asia, has entered into a distribution partnership with Trinature Wellness in Malaysia to introduce its gut microbiome test, BugSpeaks, to the Malaysian market. This partnership is part of Leucine Rich Bio’s ongoing expansion into Southeast Asia.

BugSpeaks is a non-invasive, at-home gut microbiome test that uses next-generation sequencing and proprietary algorithms to analyse microbial composition. The test provides a disease susceptibility index along with personalised dietary and supplement recommendations. It has been clinically validated through a trial published in PeerJ, demonstrating its role in improving clinical outcomes for hyperglycemia patients through microbiome-based dietary interventions. The test is backed by ISO 9001:2015 and ISO 17025:2017 certifications, along with NABH accreditation.

Leucine Rich Bio has established a presence in international markets through collaborations with Cognoa International Inc. in the Philippines, Medsol Diagnostics in the UAE, and distributors in Thailand and Brazil. These partnerships have helped the company serve over 15,000 customers worldwide, positioning BugSpeaks as a tool for preventive healthcare.

Dr Debojyoti Dhar, Co-Founder and Director of Business Development and Innovation at Leucine Rich Bio, stated, “Our partnership with Trinature Wellness is a bold step toward revolutionising health in Malaysia. BugSpeaks isn’t just a test—it’s a movement to empower people with precise, science-driven insights to transform their lives. We’re breaking barriers and redefining wellness, one gut at a time.”

Through this collaboration, Trinature Wellness will bring BugSpeaks to the Malaysian market, expanding access to microbiome-based health solutions. Leucine Rich Bio continues to focus on microbiome research and innovation, advancing personalised healthcare globally.